As the debate on drug policy and law reform gathers momentum on the international stage, the failings of the three UN drug control conventions (1961, 1971 and 1988) have come into stark relief. Criticisms of the global drug control regime established by the drug treaties have now entered the...

The problems associated with the global drug trade are amongst the most challenging and intractable of all those facing policy-makers. The global drug prohibition system is widely acknowledged as a costly and counterproductive failure, not only presiding over a massive expansion of the problem...

Three months into the COVID-19 outbreak caused by a novel strain of coronavirus (SARS-CoV-2), the world is still in search of an effective therapeutic drug. Experimental drugs developed for other infections, such as Gilead's remdesivir, have been repurposed with unclear success. A recent small...

IDPC was set up in 2007 as a response to the need for a global communication and advocacy structure in the area of drug policy. Since then, IDPC has become a dynamic collaborative initiative which has gradually expanded both its membership and activities to influence national and international...

Illicit trade has long been a central feature of Latin America’s engagement in the world. In this chapter we first briefly sketch the scope and dimensions of illicit trade in the region, and stress the importance of various types of power asymmetries. Drawing on illustrations primarily from...

Pharmaceutical drug analysis (PDA), besides quantifying drugs and related substances (RS), can enrich drug discovery (DD) by suggesting new leads. PDA may be extended towards comparative in-silico predictions for drugs and RS. This may lead to the assessment of drug likeliness of nontoxic RS as...